The Leading Cardiomyocyte Assay
for safety and efficacy
Measures and interprets drug effects on cardiac cell function at clinically relevant doses
Our unique technology is designed to eliminate risk at an earlier stage in development
The only assay to simultaneously measure voltage, calcium, and contractility in the same cells
Start a study with Clyde
Clyde’s CellOPTIQ® has helped many of the world's best pharma companies solve complex problems more effectively and less expensively than doing so in-house.
Whether you have a current cardiovascular issue or alternatively would like to prevent late stage failures Clyde can help.
Most of our standard studies are completed within 2 weeks.
To enquire about how Clyde could help with your project complete the enquiry form below and we’ll be get back to you as soon as we can. Alternatively email us at firstname.lastname@example.org